MedPath

FoodRx for Obesity Treatment

Not Applicable
Active, not recruiting
Conditions
Food Insecurity
Obesity
Interventions
Behavioral: BWL+VOUCHER
Behavioral: BWL+HOME
Behavioral: Behavioral weight loss counseling (BWL)
Registration Number
NCT05635019
Lead Sponsor
University of Pennsylvania
Brief Summary

This study is a 3-group, parallel design, randomized controlled trial (RCT) in 105 adults with obesity and food insecurity that will compare BWL-Alone (including standard-of-care referral and connection with community food resources; n=35) to BWL plus food supplementation with either food vouchers (BWL+VOUCHER; n=35) or home-delivered, medically tailored groceries consistent with BWL recommendations (BWL+HOME; n=35). All groups will have BWL treatment provided for 24 weeks per clinical guidelines. Food vouchers and HOME will be provided for 24 weeks of treatment. Assessments will be conducted at baseline, and weeks 12 and 24.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
105
Inclusion Criteria
  1. Provision of signed and dated informed consent form
  2. Stated willingness to comply with all study procedures and availability for the duration of the study
  3. Age >18 years
  4. BMI >30 kg/m2 at screening visit
  5. Screening positive for food insecurity using a score of >3 on the 10-item US Adult Food Security Survey Module109
  6. Completion of baseline assessments
  7. Ability to engage in physical activity (i.e., can walk at least 2 blocks)
  8. Willing and able to provide pictures of food receipts to study team (or mail actual receipts)
  9. Ability to reliably receive packages at a consistent location in a timely manner
  10. Telephone or internet service to communicate with study staff
  11. For females of reproductive potential: agreement to use of highly effective contraception for during study participation
Exclusion Criteria
  1. Serious medical conditions (e.g., type 1 or type 2 diabetes, renal failure) that may pose a risk to the participant during intervention, cause a change in weight, or limit ability to adhere to the program's behavioral recommendations
  2. Significant psychiatric conditions (e.g., active substance abuse, schizophrenia) that may pose a risk to the participant during intervention, cause a change in weight, or limit ability to adhere to the program's behavioral recommendations
  3. Breastfeeding, pregnant or planning pregnancy in the next 6 months
  4. Planned move from the Philadelphia area in the next 6 months
  5. Weight loss of >5 kg in the previous 90 days
  6. Recently began a course of or changed the dosage of medication that can cause significant weight change (±5 kg)
  7. Previous or planned obesity treatment with surgery (excluding lap band if removed for >1 year) or a weight-loss device
  8. Use of prescription or over the counter medications for chronic weight management in the past 3 months
  9. Household member already participating in study due to potential contamination effects
  10. Lack of stable residence and ability to store and prepare food

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BWL+VOUCHERBWL+VOUCHERBWL counseling and gift cards to grocery stores
BWL+HOMEBWL+HOMEBWL counseling and home-delivered boxes of groceries
BWL+VOUCHERBehavioral weight loss counseling (BWL)BWL counseling and gift cards to grocery stores
Behavioral weight loss counseling (BWL) aloneBehavioral weight loss counseling (BWL)BWL counseling alone
BWL+HOMEBehavioral weight loss counseling (BWL)BWL counseling and home-delivered boxes of groceries
Primary Outcome Measures
NameTimeMethod
Percent initial weight loss at 24 weeks (BWL+VOUCHER and BWL+HOME vs BWL-Alone)Change from baseline to 24 weeks

Comparison of BWL+VOUCHER and BWL+HOME vs BWL-Alone in weight loss (percent of initial weight) at 24 weeks.

Secondary Outcome Measures
NameTimeMethod
General health-related quality of life (BWL+VOUCHER vs BWL+HOME)Change from baseline to 24 weeks

Change from baseline to week 24 in general health-related quality of life as assessed with the Short Form-36. Scores range from 0 (worse) to 100 (best).

General health-related quality of life (BWL+VOUCHER and BWL+HOME vs BWL-Alone)Change from baseline to 24 weeks

Change from baseline to week 24 in general health-related quality of life as assessed with the Short Form-36. Scores range from 0 (worse) to 100 (best).

Weight-related quality of life (BWL+VOUCHER and BWL+HOME vs BWL-Alone)Change from baseline to 24 weeks

Change from baseline to week 24 in weight-related quality of life as assessed with the Impact of Weight on Quality of Life-Lite. Scores range from 0 (worse) to 100 (best).

Dietary quality as assessed by the Healthy Eating Index (BWL+VOUCHER and BWL+HOME vs BWL-Alone)Change from baseline to 24 weeks

Change from baseline to week 24 in Healthy Eating Index scores as measured with the Automated Self-Administered 24-Hour (ASA24) Dietary Assessment Tool. Scores range from 0 (worse) to 100 (best).

Weight-related quality of life (BWL+VOUCHER vs BWL+HOME)Change from baseline to 24 weeks

Change from baseline to week 24 in weight-related quality of life as assessed with the Impact of Weight on Quality of Life-Lite. Scores range from 0 (worse) to 100 (best).

Percent initial weight loss at 24 weeks (BWL+HOME vs BWL+VOUCHER)Change from baseline to 24 weeks

Comparison of BWL+HOME vs BWL+VOUCHER in weight loss (percent of initial weight) at 24 weeks.

Dietary quality as assessed by skin carotenoid levels (BWL+VOUCHER and BWL+HOME vs BWL-Alone)Change from baseline to 24 weeks

Change from baseline to week 24 in skin carotenoid levels

Dietary quality as assessed by skin carotenoid levels (BWL+VOUCHER vs BWL+HOME)Change from baseline to 24 weeks

Change from baseline to week 24 in skin carotenoid levels

Dietary quality as assessed by the Healthy Eating Index (BWL+VOUCHER vs BWL+HOME)Change from baseline to 24 weeks

Change from baseline to week 24 in Healthy Eating Index scores as measured with the ASA24. Scores range from 0 (worse) to 100 (best).

Trial Locations

Locations (1)

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath